Post hoc analyses of SHIFT and PARADIGM-HF highlight the importance of chronic Chagas' cardiomyopathy Comment on: “Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial” by Bocchi et al.

Ramires, F. J.A. et al. (2018) Post hoc analyses of SHIFT and PARADIGM-HF highlight the importance of chronic Chagas' cardiomyopathy Comment on: “Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial” by Bocchi et al. ESC Heart Failure, 5(6), pp. 1069-1071. (doi:10.1002/ehf2.12355) (PMID:30298996) (PMCID:PMC6300803)

[img]
Preview
Text
160053.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial.

203kB

Abstract

No abstract available.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:McMurray, Professor John
Authors: Ramires, F. J.A., Martinez, F., Gómez, E. A., Demacq, C., Gimpelewicz, C. R., Rouleau, J. L., Solomon, S. D., Swedberg, K., Zile, M. R., Packer, M., and McMurray, J. J.V.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences
Journal Name:ESC Heart Failure
Publisher:Wiley
ISSN:2055-5822
ISSN (Online):2055-5822
Published Online:09 October 2018
Copyright Holders:Copyright © 2018 The Authors
First Published:First published in ESC Heart Failure 5(6): 1069-1071
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record